AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionGreat Lakes Advisors, Llc
Latest Disclosed Ownership543,816 shares
Latest Disclosed Value $ 118,275,208
Great Lakes Advisors, Llc reports 8.70% decrease in ownership of ABBV / AbbVie Inc.

On May 11, 2026 - Great Lakes Advisors, Llc filed a 13F-HR form disclosing ownership of 543,816 shares of AbbVie Inc. (MX:ABBV) valued at $118,275,208 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 595,628 shares of AbbVie Inc.. This represents a change in shares of -8.70% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AbbVie COM 00287Y109 543,816 -51,812 -8.70 118,275 -13.09 0.2876
2026-02-12 2025-12-31 13F AbbVie COM 00287Y109 595,628 -8,781 -1.45 136,096 -2.75 1.1097
2025-11-03 2025-09-30 13F AbbVie COM 00287Y109 604,409 -6,773 -1.11 139,946 23.36 1.1681
2025-08-11 2025-06-30 13F AbbVie COM 00287Y109 611,182 -239,493 -28.15 113,448 -36.17 0.9508
2025-05-16 2025-03-31 13F AbbVie COM 00287Y109 850,675 -21,384 -2.45 177,721 14.69 1.5897
2025-02-10 2024-12-31 13F AbbVie COM 00287Y109 872,059 9,957 1.15 154,965 -8.98 1.3254
2024-11-04 2024-09-30 13F AbbVie COM 00287Y109 862,102 -2,108 -0.24 170,248 14.85 1.4254
2024-08-06 2024-06-30 13F AbbVie COM 00287Y109 864,210 143,263 19.87 148,229 12.91 1.3152
2024-05-08 2024-03-31 13F ABBVIE CS 00287Y109 720,947 23,744 3.41 131,285 21.51 1.1134
2024-02-08 2023-12-31 13F AbbVie COM 00287Y109 697,203 -179,891 -20.51 108,045 -17.36 1.0294
2023-11-07 2023-09-30 13F AbbVie COM 00287Y109 877,094 182,823 26.33 130,739 39.77 1.1906
2023-08-10 2023-06-30 13F AbbVie COM 00287Y109 694,271 -156,499 -18.39 93,539 -31.01 0.9345
2023-05-10 2023-03-31 13F AbbVie COM 00287Y109 850,770 433,447 103.86 135,587 1,609.80 1.2319
2023-02-09 2022-12-31 13F AbbVie COM 00287Y109 417,323 9,370 2.30 7,931 -85.52 0.4544
2022-11-09 2022-09-30 13F AbbVie COM 00287Y109 407,953 -29,728 -6.79 54,752 -18.32 1.1953
2022-08-09 2022-06-30 13F AbbVie COM 00287Y109 437,681 -123,749 -22.04 67,035 -26.35 1.3253
2022-05-06 2022-03-31 13F AbbVie COM 00287Y109 561,430 98,413 21.25 91,014 45.17 1.1632
2022-05-06 2022-03-31 13F AbbVie COM 00287Y109 551,475 89,400
2022-02-09 2021-12-31 13F AbbVie COM 00287Y109 463,017 8,381 1.84 62,693 27.84 0.9541
2021-11-09 2021-09-30 13F AbbVie COM 00287Y109 454,636 1,911 0.42 49,041 -3.83 0.7647
2021-08-11 2021-06-30 13F AbbVie COM 00287Y109 452,725 24,106 5.62 50,994 9.93 0.7693
2021-05-03 2021-03-31 13F AbbVie COM 00287Y109 428,619 -2,041 -0.47 46,386 0.52 0.7494
2021-02-09 2020-12-31 13F AbbVie COM 00287Y109 430,660 3,461 0.81 46,145 23.32 0.8352
2020-11-04 2020-09-30 13F AbbVie COM 00287Y109 427,199 769 0.18 37,418 -10.63 0.7917
2020-08-07 2020-06-30 13F AbbVie COM 00287Y109 426,430 -174,403 -29.03 41,867 -8.54 1.0157
2020-05-08 2020-03-31 13F AbbVie COM 00287Y109 600,833 -53,741 -8.21 45,778 -21.01 1.3363
2020-02-07 2019-12-31 13F AbbVie COM 00287Y109 654,574 -47,988 -6.83 57,956 8.94 1.2440
2019-11-06 2019-09-30 13F AbbVie COM 00287Y109 702,562 -2,589 -0.37 53,198 3.74 1.1682
2019-08-05 2019-06-30 13F AbbVie COM 00287Y109 705,151 86,460 13.97 51,278 2.84 1.1175
2019-05-07 2019-03-31 13F AbbVie COM 00287Y109 618,691 -9,342 -1.49 49,860 -13.88 1.1093
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 628,033 -19,751 -3.05 57,898 -5.50 1.3718
2018-11-30 2018-09-30 13F/A-2 AbbVie COM 00287Y109 647,784 45,742 7.60 61,267 9.84 1.3519
2018-11-15 2018-09-30 13F/A-1 ABBVIE COM 00287Y109 13,281 -634,503 1,256 0.2047
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 602,042 0 55,779
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 602,042 -75,515 -11.15 55,779 -3.03 1.3075
2018-05-07 2018-03-31 13F ABBVIE CS 00287Y109 677,557 229,535 51.23 57,523 32.76 1.3701
2018-02-07 2017-12-31 13F ABBVIE CS 00287Y109 448,022 -10,505 -2.29 43,328 6.34 0.9525
2017-11-13 2017-09-30 13F ABBVIE CS 00287Y109 458,527 -202,142 -30.60 40,744 -14.95 0.9583
2017-08-07 2017-06-30 13F ABBVIE CS 00287Y109 660,669 -225,782 -25.47 47,905 -17.06 1.1751
2017-05-09 2017-03-31 13F ABBVIE INC COM CS 00287Y109 886,451 -27,189 -2.98 57,759 0.96 1.4863
2017-02-10 2016-12-31 13F ABBVIE INC COM CS 00287Y109 913,640 197,302 27.54 57,212 26.63 1.5031
2016-11-07 2016-09-30 13F ABBVIE CS 00287Y109 716,338 -36,484 -4.85 45,181 -3.06 1.2253
2016-08-12 2016-06-30 13F ABBVIE INC COM CS 00287Y109 752,822 72,416 10.64 46,608 19.93 1.2688
2016-05-11 2016-03-31 13F ABBVIE CS 00287Y109 680,406 76,058 12.59 38,864 8.55 1.0628
2016-02-12 2015-12-31 13F ABBVIE INC COM CS 00287Y109 604,348 -43,953 -6.78 35,802 -0.06 1.0737
2015-10-30 2015-09-30 13F ABBVIE CS 00287Y109 648,301 52,623 8.83 35,824 -10.49 1.1109
2015-08-12 2015-06-30 13F ABBVIE INC COM CS 00287Y109 595,678 69,941 13.30 40,024 30.05 1.2170
2015-05-06 2015-03-31 13F ABBVIE INC COM CS 00287Y109 525,737 181,998 52.95 30,776 36.82 0.9414
2015-02-11 2014-12-31 13F ABBVIE INC COM CS 00287Y109 343,739 541 0.16 22,494 13.49 0.6981
2014-11-20 2014-09-30 13F ABBVIE INC COM CS 00287Y109 343,198 -17,620 -4.88 19,820 -2.68 0.6644
2014-08-19 2014-06-30 13F ABBVIE INC COM CS 00287Y109 360,818 12,327 3.54 20,366 13.70 0.8386
2014-05-22 2014-03-31 13F ABBVIE INC COM COMMON 00287Y109 348,491 -3,286 -0.93 17,912 -3.58 0.7786
2014-05-22 2013-12-31 13F/A-1 ABBVIE INC COM com 00287Y109 351,777 -132,425 -27.35 18,578 -14.23 0.8429
2014-02-24 2013-12-31 13F ABBVIE INC COM com 00287Y109 351,777 18,578
2013-11-27 2013-09-30 13F ABBVIE INC COM COMMON 00287Y109 484,202 -20,994 -4.16 21,659 3.77 0.9731
2013-08-16 2013-06-30 13F ABBVIE COM 00287Y109 505,196 505,196 20,873 0.9782
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.